Related Experiment Video
Updated: Aug 8, 2026

Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections
Published on: October 31, 2017
[Present and future choice of pharmaceutical forms for intravaginal administration. II. Barrier systems and vaginal
1Laboratoire de pharmacie galénique et biopharmacie, Université de Bordeaux II, France.
Abstract:
In part I of this review, various vaginal products for local and systemic treatment have been described and discussed. Part II is reserved to other intravaginal contraceptive systems. Some devices as diaphragms, sponges, ... have a mechanical contraceptive advantage associated or not with a spermicidal activity and can or cannot protect against venereal diseases. Other devices like intravaginal rings allow a long-acting and controlled release of contraceptive hormones and it is quite possible that they replace orale contraceptive dosage forms. Various approaches in designs, safety, effectiveness, inconvenience and advantages are discussed.
Related Concept Videos
Birth Control Methods
Modified-Release Drug Delivery Systems: Overview
Oral Drug Delivery Systems: Introduction
Oral Drug Delivery Systems: Continuous-Release Systems
Oral Drug Delivery Systems: Delayed-Release Systems
Intrauterine Drug Delivery Systems

